Immunotherapy Development

Creative Biolabs is a leading service provider that focuses on cell therapy for years. By combining cutting edge technologies with proprietary innovations, scientists at Creative Biolabs provide a full range of novel therapies development services based on diverse immune cells, such as DC cells, T cells, and NK cells. Our technology provides a broadly applicable combination treatment for a wide range of disease types. Nowadays, we are committed to bringing deep domain expertise to assist our clients in achieving their strategic and operational objectives.

Introduction to Immunotherapy

In the past few years, a wide variety of immune cells, including cytokine-induced killer cells (CIKs), dendritic cells (DCs), T cells, and natural killer cells (NKs), have been identified by many scientists and organizations. They have widely used for developing various cell therapies to treat human diseases, especially cancers. The results have indicated that these cells can get access to and further eliminate the malignant sites in patients. As a consequence, a large number of cell therapies have been widely used for increasing immune responses to more efficiently target and kill disease-associated cells, such as cancer cells. For instance, T cell therapy has been generated by transferring autologous or allogeneic T cells into target hosts to trigger passive immunization in patients. Meanwhile, modified T cells, including DC-CIK cells and chimeric antigen receptor (CAR) T cells, have been also considered as effective strategies for cancer immunotherapy, showing great success in diverse populations.

Immunotherapy Development. Fig.1 Immunotherapy Development.

Our Services for Immunotherapy

There is evidence to show that immune cells play a significant role in controlling and killing tumors in animal models and clinical trials. Creative Biolabs has applied industry solutions to the unique challenge of the immune cell therapy field. In our company, we provide a wide range of services to meet any special requirement of your projects, spanning from high-level corporate strategy development to detailed technical implementation. In general, we will help you develop an effective protocol that reduces complexity, time and risk for your cell therapy development projects. Furthermore, the product profile will be designed to guide every stage of the development process. In addition, we can also provide data verification, project feasibility analysis, risk assessment, commercialization and pricing strategies generation, as well as project consulting services to help clients realize their goals of bringing therapies to patients. Recently, we have divided our immunotherapy platform into several parts based on immune cell types, including but not limited to:

With over years of experience in immunotherapy, Creative Biolabs offers a large collection of immune cell-based immunotherapy development services for different disease's targets. Our client-focused, integrated team will anticipate challenges, overcome difficulties and successfully convert various potential targets into commercial products. For more information, please feel free to contact us or send us an inquiry.


  1. Qiao, G.; et al. Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study. Clin Cancer Res. 2019, 25(5): 1494-1504.
Let's Get Started
Contact Us

Follow us on
Copyright © 2024 Creative Biolabs. All Rights Reserved.